What is ULYX's health score?

Urgent.ly Inc. (ULYX) has a TradeApes health score of 43 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ULYX's estimated fair value?

Based on our 5-year discounted cash flow model, Urgent.ly Inc.'s estimated fair value is $111.36 per share, representing a 1926.6% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ULYX undervalued or overvalued?

Our model currently rates ULYX as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ULYX... Refresh in a moment for the full analysis.

Urgent.ly Inc. (ULYX)

Technology Undervalued low weak

$5.5

Updated: 2026-06-04

TradeApes Score

Financial Strength

40 Weak

Operating Trend

55 Mixed

Relative Value

40 Weak

Capital Allocation

35 Weak

Risk

35 Weak

Est. Fair Value $111.36

DCF Upside +1926.6%

Sector Rank #1455 of 7819

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.